| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 技术服务收入(元) | - | 368,573,003.35 | - | 300,126,920.06 | 147,209,070.21 |
| 生物制药报告分部(元) | 78,351,402.74 | - | 78,362,920.69 | - | 76,818,474.75 |
| 体外诊断试剂分部(元) | 2,718,511.27 | - | 2,004,996.74 | - | 1,546,599.94 |
| 医药技术服务报告分部(元) | 186,748,564.57 | - | 179,715,029.14 | - | 153,031,377.06 |
| 注射用鼠神经生长因子(金路捷)(元) | - | 132,722,293.47 | - | 146,127,611.26 | 67,909,073.51 |
| 原料药及医药中间体(元) | 16,549,575.26 | - | 23,308,194.36 | - | 155,774,194.91 |
| 其他(元) | 256,500.95 | 100,989,010.09 | 116,784.60 | 242,371,460.39 | 61,578.82 |
| 营业成本(元) | |||||
| 技术服务收入(元) | - | 211,484,456.77 | - | 128,482,814.76 | 54,284,036.92 |
| 生物制药报告分部(元) | - | - | - | - | - |
| 体外诊断试剂分部(元) | - | - | - | - | - |
| 医药技术服务报告分部(元) | - | - | - | - | - |
| 注射用鼠神经生长因子(金路捷)(元) | - | 23,776,808.01 | - | 29,333,273.89 | 12,391,124.10 |
| 原料药及医药中间体(元) | - | - | - | - | 130,052,786.34 |
| 其他(元) | - | 109,793,788.24 | - | 197,065,785.81 | - |
| 毛利(元) | |||||
| 技术服务收入(元) | - | 157,088,546.58 | - | 171,644,105.30 | 92,925,033.29 |
| 生物制药报告分部(元) | - | - | - | - | - |
| 体外诊断试剂分部(元) | - | - | - | - | - |
| 医药技术服务报告分部(元) | - | - | - | - | - |
| 注射用鼠神经生长因子(金路捷)(元) | - | 108,945,485.46 | - | 116,794,337.37 | 55,517,949.41 |
| 原料药及医药中间体(元) | - | - | - | - | 25,721,408.57 |
| 其他(元) | - | -8,804,778.15 | - | 45,305,674.58 | - |
| 毛利率(%) | |||||
| 技术服务收入(%) | - | 42.62 | - | 57.19 | 63.12 |
| 生物制药报告分部(%) | - | - | - | - | - |
| 体外诊断试剂分部(%) | - | - | - | - | - |
| 医药技术服务报告分部(%) | - | - | - | - | - |
| 注射用鼠神经生长因子(金路捷)(%) | - | 82.09 | - | 79.93 | 81.75 |
| 原料药及医药中间体(%) | - | - | - | - | 16.51 |
| 其他(%) | - | -8.72 | - | 18.69 | - |
| 收入构成(%) | |||||
| 技术服务收入(%) | - | 61.20 | - | 43.58 | 24.44 |
| 生物制药报告分部(%) | 27.53 | - | 27.64 | - | 12.75 |
| 体外诊断试剂分部(%) | 0.96 | - | 0.71 | - | 0.26 |
| 医药技术服务报告分部(%) | 65.61 | - | 63.39 | - | 25.41 |
| 注射用鼠神经生长因子(金路捷)(%) | - | 22.04 | - | 21.22 | 11.27 |
| 原料药及医药中间体(%) | 5.81 | - | 8.22 | - | 25.86 |
| 其他(%) | 0.09 | 16.77 | 0.04 | 35.20 | 0.01 |
| 毛利构成(%) | |||||
| 技术服务收入(%) | - | 61.07 | - | 51.43 | 53.35 |
| 生物制药报告分部(%) | - | - | - | - | 0.00 |
| 体外诊断试剂分部(%) | - | - | - | - | 0.00 |
| 医药技术服务报告分部(%) | - | - | - | - | 0.00 |
| 注射用鼠神经生长因子(金路捷)(%) | - | 42.35 | - | 35.00 | 31.88 |
| 原料药及医药中间体(%) | - | - | - | - | 14.77 |
| 其他(%) | - | -3.42 | - | 13.57 | 0.00 |